Drug
Lunesta
Lunesta: highest development phase Post-Market, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lunesta NCT00460993 | Post-Market | Poor Quality Sleep |
Latest
No recent events.
Follow Lunesta on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.